EOM Pharmaceuticals Inc. (IMMUNOCELLULAR THERAPEUTICS LTD.)
Company Snapshot
Founded: 2020
Entity Type: Private
Region: U.S.
Headquarter: New Jersey, U.S.
Key Geographics: North America
Corporate Address: 136 Summit Avenue Suite 100, Montvale New Jersey 07645 U.S. Tel. +1-(201)-351-0605 www.eompharma.com
Company Overview
ImmunoCellular Therapeutics Ltd. is a clinical-stage company that is developing immune-based therapies for the treatment of brain and other cancers. Its proprietary technology includes cancer immunotherapy, dendritic cell (DC)-based immunotherapies and a stem-to-T-cell platform. The cancer immunotherapeutic activates the body’s immune system against multiple tumor-associated antigens, which are overexpressed on cancer stem cells and other cancer cells. DC-based immunotherapeutics are developed from the patients’ own cells, which offers antigens to the immune system. The stem-to-T-cell platform helps to kill the tumor by creating a population of antigen specific T cells.
EOM Pharmaceuticals Inc. (IMMUNOCELLULAR THERAPEUTICS LTD.) In Reports
EOM Pharmaceuticals Inc. (IMMUNOCELLULAR THERAPEUTICS LTD.) In News
Company's Business Segments
- Drugs Development : The company engaged in developing drugs that could transform therapeutic paradigms and improve the quality of life for patients suffering from debilitating and infectious diseases, autoimmune diseases (rheumatoid arthritis), and cachexia associated with AIDS and cancer.
Applications/End User Industries
- Healthcare
- Life Sciences